Major pharmaceutical companies are racing to launch breakthrough drugs to treat advanced melanoma, the deadliest form of skin cancer.
These majors include:
Bristol-Myers Squibb
Roche Holding
Merck
AstraZeneca
I wonder which of these four will be the first in making a call to Cellmid & Co.
The mind boggles when looking at the $'s on offer for a ground breaking new drugs.
The above four are no different to other any other food, engineering or manufacturing businesses; they need new innovative products to grow revenue streams and be a market leader
Well, Midkine can possibly provide that opportunity.
- Forums
- ASX - By Stock
- AN1
- Is this it?
Is this it?
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online